Novel treatment paradigm for elderly patients with multiple myeloma

por Palumbo, Antonio, Magarotto, Valeria
Publicado 2011

Lenalidomide in the Treatment of Young Patients with Multiple Myeloma: From Induction to Consolidation/Maintenance Therapy

por Lupo, Barbara, Palumbo, Antonio
Publicado 2012

Lenalidomide in the treatment of plasma cell dyscrasia: state of the art and perspectives

por Palumbo, Antonio, Cavallo, Federica
Publicado 2013

Diagnosis and therapy of multiple myeloma

por Palumbo, Antonio, Cerrato, Chiara
Publicado 2013

Venous and arterial thrombotic risks with thalidomide: evidence and practical guidance

por Palumbo, Antonio, Palladino, Carmela
Publicado 2012

Review of thalidomide in the treatment of newly diagnosed multiple myeloma

por Cavallo, Federica, Boccadoro, Mario, Palumbo, Antonio
Publicado 2007

Age and aging in blood disorders: multiple myeloma

por Zweegman, Sonja, Palumbo, Antonio, Bringhen, Sara, Sonneveld, Pieter
Publicado 2014

Lenalidomide in the Treatment of Lymphoproliferative Disorders and Multiple Myeloma

por Liberati, Anna Marina, Vitolo, Umberto, Palumbo, Antonio, Cortelezzi, Agostino
Publicado 2013

Thromboembolic Events With Lenalidomide-based Therapy for Multiple Myeloma

por Menon, Smitha Patiyil, Rajkumar, Vincent, Lacy, Martha, Falco, Patrizia, Palumbo, Antonio
Publicado 2008

Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study

por Cella, David, McKendrick, Jan, Kudlac, Amber, Palumbo, Antonio, Oukessou, Abderrahim, Vij, Ravi, Zyczynski, Teresa, Davis, Catherine
Publicado en Ann Hematol (2018)

Genetic instability in the tumor microenvironment: a new look at an old neighbor

por Palumbo, Antonio, de Oliveira Meireles Da Costa, Nathalia, Bonamino, Martin Hernan, Ribeiro Pinto, Luis Felipe, Nasciutti, Luiz Eurico
Publicado en Mol Cancer (2015)

Proteasome inhibitors in multiple myeloma: 10 years later

por Moreau, Philippe, Richardson, Paul G., Cavo, Michele, Orlowski, Robert Z., San Miguel, Jesús F., Palumbo, Antonio, Harousseau, Jean-Luc
Publicado 2012

Potential Therapeutic Effects of Underground Parts of Kalanchoe gastonis-bonnieri on Benign Prostatic Hyperplasia

por Palumbo, Antonio, Casanova, Livia Marques, Corrêa, Maria Fernanda Paresqui, Da Costa, Nathalia Meireles, Nasciutti, Luiz Eurico, Costa, Sônia Soares
Publicado en Evid Based Complement Alternat Med (2019)

The Use of Middle Latency Auditory Evoked Potentials (MLAEP) as Methodology for Evaluating Sedation Level in Propofol-Drug Induced Sleep Endoscopy (DISE) Procedure

por Arigliani, Michele, Toraldo, Domenico M., Ciavolino, Enrico, Lattante, Caterina, Conte, Luana, Arima, Serena, Arigliani, Caterina, Palumbo, Antonio, De Benedetto, Michele
Publicado en Int J Environ Res Public Health (2021)

Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or...

por Dimopoulos, Meletios A., Delforge, Michel, Hájek, Roman, Kropff, Martin, Petrucci, Maria T., Lewis, Philip, Nixon, Annabel, Zhang, Jingshan, Mei, Jay, Palumbo, Antonio
Publicado 2013

Impact of maintenance therapy on subsequent treatment in patients with newly diagnosed multiple myeloma: use of “progression-free survival 2” as a clinical trial end-point

por Dimopoulos, Meletios A., Petrucci, Maria T., Foà, Robin, Catalano, John, Kropff, Martin, Terpos, Evangelos, Zhang, Jingshan, Grote, Lara, Jacques, Christian, Palumbo, Antonio
Publicado en Haematologica (2015)

Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged ≥ 65 years treated with melphalan, prednisone and lenalidomide followed...

por Dimopoulos, Meletios A., Palumbo, Antonio, Hajek, Roman, Kropff, Martin, Petrucci, Maria Teresa, Lewis, Philip, Millar, Stefanie, Zhang, Jingshan, Mei, Jay, Delforge, Michel
Publicado 2014

Esophageal Cancer Development: Crucial Clues Arising from the Extracellular Matrix

por Palumbo, Antonio, Meireles Da Costa, Nathalia, Pontes, Bruno, Leite de Oliveira, Felipe, Lohan Codeço, Matheus, Ribeiro Pinto, Luis Felipe, Nasciutti, Luiz Eurico
Publicado en Cells (2020)

High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib

por Gambella, Manuela, Rocci, Alberto, Passera, Roberto, Gay, Francesca, Omedè, Paola, Crippa, Claudia, Corradini, Paolo, Romano, Alessandra, Rossi, Davide, Ladetto, Marco, Boccadoro, Mario, Palumbo, Antonio
Publicado 2014

The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status

por Foglietta, Myriam, Castella, Barbara, Mariani, Sara, Coscia, Marta, Godio, Laura, Ferracini, Riccardo, Ruggeri, Marina, Muccio, Vittorio, Omedé, Paola, Palumbo, Antonio, Boccadoro, Mario, Massaia, Massimo
Publicado 2014